fentanyl "actavis" 25 mikrogram/time depotplastre
actavis group ptc ehf. - fentanyl - depotplastre - 25 mikrogram/time
fentanyl "actavis" 50 mikrogram/time depotplastre
actavis group ptc ehf. - fentanyl - depotplastre - 50 mikrogram/time
fentanyl "actavis" 75 mikrogram/time depotplastre
actavis group ptc ehf. - fentanyl - depotplastre - 75 mikrogram/time
fentanyl "kalceks" 50 mikrogram/ml injektionsvæske, opløsning
kalceks as - fentanylcitrat - injektionsvæske, opløsning - 50 mikrogram/ml
fentanyl carefarm 12 mikrogram/time depotplastre
orifarm a/s - fentanyl - depotplastre - 12 mikrogram/time
fentanyl carefarm 25 mikrogram/time depotplastre
orifarm a/s - fentanyl - depotplastre - 25 mikrogram/time
fentanyl carefarm 50 mikrogram/time depotplastre
orifarm a/s - fentanyl - depotplastre - 50 mikrogram/time
instanyl
takeda pharma a/s - fentanyl citrate - pain; cancer - analgetika - instanyl er indiceret til behandling af gennembrudssmerter hos voksne, der allerede modtager opioidbehandling ved vedligeholdelse af kronisk kræftpine. gennembrudssmerter er en forbigående forværring af smerte, der opstår på baggrund af ellers kontrolleret vedvarende smerte. patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.
fentanyl "hameln" 50 mikrogram/ml injektionsvæske, opløsning
hameln pharma gmbh - fentanylcitrat - injektionsvæske, opløsning - 50 mikrogram/ml
fentanyl carefarm 75 mikrogram/time depotplastre
orifarm a/s - fentanyl - depotplastre - 75 mikrogram/time